Blood Group Genotyping for Sickle Cell and Thalassaemia

{
  "awards": [
    {
      "aboveThreshold": true,
      "contractPeriod": {
        "endDate": "2026-03-31T23:59:59+01:00",
        "startDate": "2025-12-08T00:00:00Z"
      },
      "documents": [
        {
          "datePublished": "2025-12-05T16:13:51Z",
          "description": "Transparency notice on Find a Tender",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "080318-2025",
          "noticeType": "UK5",
          "url": "https://www.find-tender.service.gov.uk/Notice/080318-2025"
        }
      ],
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Health services",
              "id": "85100000",
              "scheme": "CPV"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "services",
      "milestones": [
        {
          "dueDate": "2025-12-05T23:59:59Z",
          "id": "1",
          "status": "scheduled",
          "type": "futureSignatureDate"
        }
      ],
      "relatedLots": [
        "1"
      ],
      "status": "pending",
      "suppliers": [
        {
          "id": "GB-NHS-T1460",
          "name": "NHSBT"
        }
      ],
      "title": "Blood Group Genotyping for Sickle Cell and Thalassaemia",
      "value": {
        "amount": 140671.0,
        "amountGross": 168805.2,
        "currency": "GBP"
      }
    }
  ],
  "buyer": {
    "id": "GB-PPON-PDPT-3135-BWWY",
    "name": "NHS England"
  },
  "date": "2025-12-05T16:13:51Z",
  "id": "080318-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-05f01d",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "region": "UKI45",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "contactPoint": {
        "email": "england.commercialqueries@nhs.net"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - central government",
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ],
        "url": "https://www.england.nhs.uk/"
      },
      "id": "GB-PPON-PDPT-3135-BWWY",
      "identifier": {
        "id": "PDPT-3135-BWWY",
        "scheme": "GB-PPON"
      },
      "name": "NHS England",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Bristol",
        "postalCode": "BS34 7QH",
        "region": "UKK12",
        "streetAddress": "500 North Bristol Park, Filton"
      },
      "contactPoint": {
        "email": "customer.services@nhsbt.nhs.uk",
        "telephone": "+44 7764280366"
      },
      "details": {
        "scale": "large",
        "url": "http://www.cromalocksmiths.com",
        "vcse": false
      },
      "id": "GB-NHS-T1460",
      "identifier": {
        "id": "T1460",
        "scheme": "GB-NHS"
      },
      "name": "NHSBT",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "C369873",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "Due to an absence of competition for technical reasons. Para 6, Schedule 5 of PA 2023 utilised.\nNHSBT have been verified as the only organisation in England that could deliver this service for the planned typing of patients with Sickle Cell Disease blood patients, thalassemia and rare inherited anaemia",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersTechnicalReasons"
      }
    ],
    "status": "complete",
    "title": "Blood Group Genotyping for Sickle Cell and Thalassaemia"
  }
}